Strides Pharma Shares Hit 52-Week High As USFDA Tentative Nod To HIV Treatment Drug – Top Speed News

Last Updated: September 15, 2023, 14:05 IST Strides Pharma’s share price jumps 11.5% on FDA’s tentative approval for generic HIV treatment drug. Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high; Details Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high after the company’s arm…

Read More